These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38086945)

  • 41. Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion.
    Ma J; Liu YC; Voss RK; Ma J; Palagani A; Caldwell E; Rosikiewicz W; Cardenas M; Foy S; Umeda M; Wilkinson MR; Inaba H; Klco JM; Rubnitz JE; Wang L
    Leukemia; 2024 May; 38(5):981-990. PubMed ID: 38429501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity.
    Gu BW; Wang Q; Wang JM; Xue YQ; Fang J; Wong KF; Chen B; Shi ZZ; Shi JY; Bai XT; Wu DH; Chen Z; Chen SJ
    Leukemia; 2003 Sep; 17(9):1858-64. PubMed ID: 12970787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.
    Kim B; Lee H; Shin S; Lee ST; Choi JR
    J Mol Diagn; 2019 Jan; 21(1):163-170. PubMed ID: 30347268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
    Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
    Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
    de Rooij JD; Hollink IH; Arentsen-Peters ST; van Galen JF; Berna Beverloo H; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Zimmermann M; Alonzo TA; Pieters R; Meshinchi S; van den Heuvel-Eibrink MM; Zwaan CM
    Leukemia; 2013 Dec; 27(12):2280-8. PubMed ID: 23531517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value.
    Codrington R; O'Connor HE; Jalali GR; Carrara P; Papaioannou M; Hart SM; Hoffbrand AV; Potter M; Prentice HG; Harrison CJ; Foroni L
    Br J Haematol; 2000 Dec; 111(4):1071-9. PubMed ID: 11167742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute myeloid leukemia with t(X;6)9p11;q23);MYB-GATA1 and female sex: GATA1 insufficiency may be insufficient for pathogenesis.
    Kovach AE; Zerkalenkova E; Zemtsova L; Borkovskaya A; Gaskova M; Kazanov M; Popov A; Baidun L; Maschan M; Maschan A; Gaynon PS; Bhojwani D; Novichkova G; Olshanskaya Y; Raca G
    Cancer Genet; 2022 Jan; 260-261():37-40. PubMed ID: 34915342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations.
    Delsing Malmberg E; Rehammar A; Pereira MB; Abrahamsson J; Samuelsson T; Ståhlman S; Asp J; Tierens A; Palmqvist L; Kristiansson E; Fogelstrand L
    J Mol Diagn; 2019 Jan; 21(1):149-162. PubMed ID: 30273780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13).
    Taketani T; Taki T; Shibuya N; Kikuchi A; Hanada R; Hayashi Y
    Cancer Res; 2002 Aug; 62(16):4571-4. PubMed ID: 12183408
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Panagopoulos I; Gorunova L; Torkildsen S; Tjønnfjord GE; Micci F; Heim S
    Cancer Genomics Proteomics; 2017; 14(6):437-443. PubMed ID: 29109093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring of minimal residual disease in acute myeloid leukemia.
    Kern W; Schoch C; Haferlach T; Schnittger S
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):283-309. PubMed ID: 16213150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
    von Bergh AR; van Drunen E; van Wering ER; van Zutven LJ; Hainmann I; Lönnerholm G; Meijerink JP; Pieters R; Beverloo HB
    Genes Chromosomes Cancer; 2006 Aug; 45(8):731-9. PubMed ID: 16646086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia.
    Aypar U; Smoley SA; Pitel BA; Pearce KE; Zenka RM; Vasmatzis G; Johnson SH; Smadbeck JB; Peterson JF; Geiersbach KB; Van Dyke DL; Thorland EC; Jenkins RB; Ketterling RP; Greipp PT; Kearney HM; Hoppman NL; Baughn LB
    Eur J Haematol; 2019 Jan; 102(1):87-96. PubMed ID: 30270457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines.
    Taketani T; Taki T; Sako M; Ishii T; Yamaguchi S; Hayashi Y
    Cancer Genet Cytogenet; 2008 Oct; 186(2):115-9. PubMed ID: 18940475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing.
    Arindrarto W; Borràs DM; de Groen RAL; van den Berg RR; Locher IJ; van Diessen SAME; van der Holst R; van der Meijden ED; Honders MW; de Leeuw RH; Verlaat W; Jedema I; Kroes WGM; Knijnenburg J; van Wezel T; Vermaat JSP; Valk PJM; Janssen B; de Knijff P; van Bergen CAM; van den Akker EB; Hoen PAC'; Kiełbasa SM; Laros JFJ; Griffioen M; Veelken H
    Leukemia; 2021 Jan; 35(1):47-61. PubMed ID: 32127641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of minimal residual disease in childhood acute myeloid leukemia.
    Miyamura T; Sakata N; Okamura T; Yasui M; Inoue M; Yagi K; Sako M; Komada Y; Matsuyama T; Oda M; Park YD; Kawa K
    Int J Hematol; 2004 Apr; 79(3):243-9. PubMed ID: 15168592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].
    Nasedkina TV; Ikonnikova AY; Tsaur GA; Karateeva AV; Ammour YI; Avdonina MA; Karachunskii AI; Zasedatelev AS
    Mol Biol (Mosk); 2016; 50(6):968-977. PubMed ID: 28064313
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First case report of a NUP98-PMX1 rearrangement in de novo acute myeloid leukemia and literature review.
    Fu W; Huang A; Cheng H; Luo Y; Gao L; Tang G; Yang J; Wang J; Ni X
    BMC Med Genomics; 2021 May; 14(1):130. PubMed ID: 34001105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Mixed Lineage Leukemia Gene (MLL)/MLLT10 Fusion Transcripts by Reverse Transcription-PCR and Sequencing in a Case of AML With a FISH-Negative Cryptic MLL Rearrangement.
    Ko K; Kwon MJ; Woo HY; Park H; Park CH; Lee ST; Kim SH
    Ann Lab Med; 2015 Jul; 35(4):469-71. PubMed ID: 26131423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.